Versant Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1K | Buy |
304
+130
| +75% | +$4.73K | ﹤0.01% | 1849 |
|
|
2025
Q1 | $6.3K | Buy |
174
+15
| +9% | +$543 | ﹤0.01% | 1937 |
|
|
2024
Q4 | $6.69K | Buy |
159
+81
| +104% | +$3.41K | ﹤0.01% | 1611 |
|
|
2024
Q3 | $4.33K | Hold |
78
| – | – | ﹤0.01% | 1341 |
|
|
2024
Q2 | $3.21K | Buy |
+78
| New | +$3.21K | ﹤0.01% | 1363 |
|
|
2023
Q3 | – | Sell |
-12
| Closed | -$554 | – | 2034 |
|
|
2023
Q2 | $554 | Buy |
+12
| New | +$554 | ﹤0.01% | 1810 |
|